A carregar...

Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?

In a group of 74 patients with advanced metastatic breast cancer, 57% of those with cytoplasmic oestrogen receptor activity in their tumours (REC+) showed a clinical response to endocrine therapy. Of 51 patients whose tumour was assayed for both REC and cytoplasmic progesterone (RPC) activity, 9/12...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barnes, D. M., Skinner, L. G., Ribeiro, G. G.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1979
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2010127/
https://ncbi.nlm.nih.gov/pubmed/230853
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!